{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:18:31Z","timestamp":1787170711643,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Several issues that affect prevention and treatment of heartworm infections require more intensive research. The incidence of heartworm infection in the USA is increasing, but the factors that underlie this trend remain incompletely understood. The contributions of climate change, vector range expansion, client compliance and resistance to macrocyclic lactones (ML) are likely interrelated and require investigation. Molecular-level research has not yet identified the causative mechanisms underlying ML resistance (MLR), but surveys of genomic markers associated with the trait reveal worrying trends in the presence and frequency of these resistance alleles. Research is needed to confirm the phenotypic relevance of these markers and to identify the gene(s) responsible for it. Developing highly inbred strains of MLR heartworms may be necessary but would require multigenerational studies of targeted breeding of selected parasites in dogs. A second issue of concern for veterinarians is the increasing extra-label use of emodepside products for the treatment of multiple anthelmintic drug resistant (MADR) canine hookworms (\n                    <jats:italic>Ancylostoma caninum<\/jats:italic>\n                    ), which are already common throughout the USA. Emodepside is not approved for use in dogs in the USA, but a cat topical product containing the drug is, and is being used orally in hookworm-infected dogs. Emodepside has activity against larval and adult stages of many filarial parasites and the safety of this drug in heartworm-infected dogs has not been reported. It is perhaps unlikely that such studies will be undertaken, given the lack of economic motivation. Nonetheless, a review of the relevant literature leads to the conclusion that the status of heartworm infection in a dog bearing an apparently MADR hookworm infection be determined before starting treatment with emodepside, with caution exercised should it ensue.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s13071-026-07327-y","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:21:37Z","timestamp":1773865297000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Current issues in heartworm chemotherapy"],"prefix":"10.1186","volume":"19","author":[{"given":"Timothy G.","family":"Geary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"7327_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.vetpar.2005.04.004","volume":"133","author":"VA Hampshire","year":"2005","unstructured":"Hampshire VA. Evaluation of efficacy of heartworm preventative products at the FDA. Vet Parasitol. 2005;133:191\u20135.","journal-title":"Vet Parasitol"},{"key":"7327_CR2","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.vetpar.2011.01.023","volume":"176","author":"C Bourguinat","year":"2011","unstructured":"Bourguinat C, Keller K, Prichard RK, Geary TG. Genetic polymorphism in Dirofilaria immitis. Vet Parasitol. 2011;176:368\u201373.","journal-title":"Vet Parasitol"},{"key":"7327_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-014-0494-6","volume":"7","author":"CN Pulaski","year":"2014","unstructured":"Pulaski CN, Malone JB, Bourguinat C, Prichard R, Geary T, Ward D, et\u00a0al. Establishment of macrocyclic lactone resistant Dirofilaria immitis isolates in experimentally infected laboratory dogs. Parasit Vectors. 2014;7:494.","journal-title":"Parasit Vectors"},{"key":"7327_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.vetpar.2015.04.002","volume":"210","author":"C Bourguinat","year":"2015","unstructured":"Bourguinat C, Lee AC, Lizundia R, Blagburn BL, Liotta JL, Kraus MS, et\u00a0al. Macrocyclic lactone resistance in Dirofilaria immitis: failure of heartworm preventives and investigation of genetic markers for resistance. Vet Parasitol. 2015;210:167\u201378.","journal-title":"Vet Parasitol"},{"key":"7327_CR5","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1053\/j.tcam.2011.09.004","volume":"26","author":"TG Geary","year":"2011","unstructured":"Geary TG, Bourguinat C, Prichard RK. Evidence for macrocyclic lactone anthelmintic resistance in Dirofilaria immitis. Top Companion Anim Med. 2011;26:186\u201392.","journal-title":"Top Companion Anim Med"},{"key":"7327_CR6","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.ijpddr.2018.06.006","volume":"8","author":"C Ballesteros","year":"2018","unstructured":"Ballesteros C, Pulaski CN, Bourguinat C, Keller K, Prichard RK, Geary TG. Clinical validation of molecular markers of macrocyclic lactone resistance in Dirofilaria immitis. Int J Parasitol Drugs Drug Resist. 2018;8:596\u2013606.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"7327_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-017-2428-6","volume":"10","author":"C Bourguinat","year":"2017","unstructured":"Bourguinat C, Keller K, Xia J, Lepage P, McTier TL, Woods DJ, et\u00a0al. Genetic profiles of ten Dirofilaria immitis isolates susceptible or resistant to macrocyclic lactone heartworm preventives. Parasit Vectors. 2017;10:504.","journal-title":"Parasit Vectors"},{"key":"7327_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijpddr.2023.07.002","volume":"23","author":"S Kumar","year":"2023","unstructured":"Kumar S, Prichard RK, Long T. Droplet digital PCR as a tool to detect resistant isolates of Dirofilaria immitis. Int J Parasitol Drugs Drug Resist. 2023;23:10\u20138.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"7327_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpddr.2025.100625","volume":"30","author":"S Kumar","year":"2026","unstructured":"Kumar S, Lalicon IA, Prichard RK, Long T. Development and evaluation of quadruplex droplet digital PCR assay for rapid detection of molecular markers associated with macrocyclic lactone resistance and susceptibility in Dirofilaria immitis. Int J Parasitol Drugs Drug Resist. 2026;30:100625.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"7327_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetpar.2024.110199","volume":"329","author":"PT Fisher","year":"2024","unstructured":"Fisher PT, Keller K, Prichard RK. Investigating Dirofilaria immitis isolates infecting domestic canines and their susceptibility\/resistance patterns to macrocyclic lactones in the northern region of the Mississippi Delta area (southeast Missouri). Vet Parasitol. 2024;329:110199.","journal-title":"Vet Parasitol"},{"key":"7327_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpddr.2025.100604","volume":"29","author":"E Curry","year":"2025","unstructured":"Curry E, Tack D, Rodriguez J, Brehm-Lowe D, Letherer J, Lineberry M, et\u00a0al. Surveillance of single nucleotide polymorphisms correlated to macrocyclic lactone resistance in Dirofilaria immitis from client-owned dogs across the United States. Int J Parasitol Drugs Drug Resist. 2025;29:100604.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"7327_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-020-04178-z","volume":"13","author":"K Kryda","year":"2020","unstructured":"Kryda K, Holzmer S, Everett WR, McCall JW, Mahabir SP, McTier TL, et\u00a0al. Preventive efficacy of four or six monthly oral doses of 24 \u00b5g\/kg moxidectin compared to six monthly doses of Heartgard\u00ae Plus or Interceptor\u00ae Plus against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs. Parasit Vectors. 2020;13:339.","journal-title":"Parasit Vectors"},{"key":"7327_CR13","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s13071-021-04708-3","volume":"14","author":"TL McTier","year":"2021","unstructured":"McTier TL, Holzmer S, Kryda K, Mahabir S, McCall JW, Trombley J, et\u00a0al. Comparative preventive efficacy of ProHeart\u00ae 12, Heartgard\u00ae Plus and Interceptor\u00ae Plus against a macrocyclic lactone-resistant strain (JYD-34) of heartworm (Dirofilaria immitis) in dogs. Parasit Vectors. 2021;14:226.","journal-title":"Parasit Vectors"},{"key":"7327_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13071-022-05180-3","volume":"15","author":"JAE Myers","year":"2022","unstructured":"Myers JAE, Holzmer S, McCall JW, Mahabir SP, McTier TL, Maeder SJ, et\u00a0al. Preventive efficacy of six monthly oral doses of Simparica Trio\u00ae, Heartgard\u00ae Plus, and Interceptor\u00ae Plus against a macrocyclic lactone-resistant strain (ZoeLA) of heartworm (Dirofilaria immitis) in dogs. Parasit Vectors. 2022;15:81.","journal-title":"Parasit Vectors"},{"key":"7327_CR15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1186\/s13071-024-06603-z","volume":"17","author":"J Prullage","year":"2024","unstructured":"Prullage J, Frost J, DiCosty U, Martin E, Dumont P, Yoon S, et\u00a0al. Preventive efficacy of six monthly doses of NexGard\u00ae PLUS or Simparica Trio\u00ae against a macrocyclic lactone-resistant isolate (JYD-34) of Dirofilaria immitis and of a single dose of NexGard PLUS against a susceptible isolate. Parasit Vectors. 2024;17:519.","journal-title":"Parasit Vectors"},{"key":"7327_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2024.1377718","volume":"11","author":"K Mwacalimba","year":"2024","unstructured":"Mwacalimba K, Sheehy J, Adolph C, Savadelis M, Kryda K, Poulsen Nautrup B. A review of moxidectin vs. other macrocyclic lactones for prevention of heartworm disease in dogs with an appraisal of two commercial formulations. Front Vet Sci. 2024;11:1377718.","journal-title":"Front Vet Sci"},{"key":"7327_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ijpddr.2019.06.002","volume":"10","author":"RK Prichard","year":"2019","unstructured":"Prichard RK, Geary TG. Perspectives on the utility of moxidectin for the control of parasitic nematodes in the face of developing anthelmintic resistance. Int J Parasitol Drugs Drug Resist. 2019;10:69\u201383.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"7327_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10010002","volume":"10","author":"E Neff","year":"2020","unstructured":"Neff E, Evans CC, Jimenez Castro PD, Kaplan RM, Dharmarajan G. Drug resistance in filarial parasites does not affect mosquito vectorial capacity. Pathogens. 2020;10:2.","journal-title":"Pathogens"},{"key":"7327_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-021-04839-7","volume":"14","author":"EW Zinser","year":"2021","unstructured":"Zinser EW, McTier TL, Kernell NS, Woods DJ. Cryogenic preservation of Dirofilaria immitis microfilariae, reactivation and completion of the life-cycle in the mosquito and vertebrate hosts. Parasit Vectors. 2021;14:367.","journal-title":"Parasit Vectors"},{"key":"7327_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetpar.2020.109125","volume":"283","author":"J Sanchez","year":"2020","unstructured":"Sanchez J, Dharmarajan G, George MM, Pulaski C, Wolstenholme AJ, Gilleard JS, et\u00a0al. Using population genetics to examine relationships of Dirofilaria immitis based on both macrocyclic lactone-resistance status and geography. Vet Parasitol. 2020;283:109125.","journal-title":"Vet Parasitol"},{"key":"7327_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-023-05762-9","volume":"16","author":"TG Geary","year":"2023","unstructured":"Geary TG. New paradigms in research on Dirofilaria immitis. Parasit Vectors. 2023;16:247.","journal-title":"Parasit Vectors"},{"key":"7327_CR22","doi-asserted-by":"publisher","first-page":"484","DOI":"10.12688\/f1000research.149854.1","volume":"13","author":"JL Dagley","year":"2024","unstructured":"Dagley JL, DiCosty U, Fricks C, Mansour A, McCall S, McCall JW, et\u00a0al. Current status of immunodeficient mouse models as substitutes to reduce cat and dog use in heartworm preclinical research. F1000Res. 2024;13:484.","journal-title":"F1000Res"},{"key":"7327_CR23","doi-asserted-by":"crossref","unstructured":"Nakhale M, Hess JA, Oliver E, Ryan NM, Mallon K, Sultan O et\u00a0al. Development of Dirofilaria immitis adult worms in NSG mice, detection of parasite-derived microRNA and comparative analysis of laboratory isolates. Sci Rep. 2026; in press.","DOI":"10.1038\/s41598-026-36209-7"},{"key":"7327_CR24","unstructured":"Mills BJ, McTier Tl, Knauer CS, Woods DJ. Anthelmintic laboratory animal model for heartworm. WO 2020\/146338 A1, 16 July 2020."},{"key":"7327_CR25","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/bs.apar.2021.12.002","volume":"115","author":"J Charlier","year":"2022","unstructured":"Charlier J, Bartley DJ, Sotiraki S, Martinez-Valladares M, Claerebout E, von Samson-Himmelstjerna G, et\u00a0al. Anthelmintic resistance in ruminants: challenges and solutions. Adv Parasitol. 2022;115:171\u2013227.","journal-title":"Adv Parasitol"},{"key":"7327_CR26","doi-asserted-by":"publisher","first-page":"866","DOI":"10.2174\/138920112800399077","volume":"13","author":"TG Geary","year":"2012","unstructured":"Geary TG, Moreno Y. Macrocyclic lactone anthelmintics: spectrum of activity and mechanisms of action. Curr Pharm Des Biotechnol. 2012;13:866\u201372.","journal-title":"Curr Pharm Des Biotechnol"},{"key":"7327_CR27","doi-asserted-by":"publisher","first-page":"20120","DOI":"10.1073\/pnas.1011983107","volume":"107","author":"Y Moreno","year":"2010","unstructured":"Moreno Y, Nabhan JF, Solomon J, Mackenzie CD, Geary TG. Ivermectin disrupts the function of the excretory-secretory apparatus in microfilariae of Brugia malayi. Proc Natl Acad Sci USA. 2010;107:20120\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7327_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.vetpar.2014.02.004","volume":"206","author":"AF Vatta","year":"2014","unstructured":"Vatta AF, Dzimianski M, Storey BE, Camus MS, Moorhead AR, Kaplan RM, et\u00a0al. Ivermectin-dependent attachment of neutrophils and peripheral blood mononuclear cells to Dirofilaria immitis microfilariae in vitro. Vet Parasitol. 2014;206:38\u201342.","journal-title":"Vet Parasitol"},{"key":"7327_CR29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13071-017-2116-6","volume":"10","author":"DS Carithers","year":"2017","unstructured":"Carithers DS. Examining the role of macrolides and host immunity in combatting filarial parasites. Parasit Vectors. 2017;10:182.","journal-title":"Parasit Vectors"},{"key":"7327_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006438","volume":"12","author":"H Harischandra","year":"2018","unstructured":"Harischandra H, Yuan W, Loghry HJ, Zamanian M, Kimber MJ. Profiling extracellular vesicle release by the filarial nematode Brugia malayi reveals sex-specific differences in cargo and a sensitivity to ivermectin. PLoS Negl Trop Dis. 2018;12:e0006438.","journal-title":"PLoS Negl Trop Dis"},{"key":"7327_CR31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ijpddr.2019.04.004","volume":"10","author":"T Berrafato","year":"2019","unstructured":"Berrafato T, Coates R, Reaves BJ, Kulke D, Wolstenholme AJ. Macrocyclic lactone anthelmintic-induced leukocyte binding to Dirofilaria immitis microfilariae: influence of the drug resistance status of the parasite. Int J Parasitol Drugs Drug Resist. 2019;10:45\u201350.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"7327_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetpar.2022.109696","volume":"304","author":"E Curry","year":"2022","unstructured":"Curry E, Prichard R. Development of rapid in vitro colorimetric enzymatic activity assay to differentiate macrocyclic lactone susceptible and resistant Dirofilaria immitis isolates. Vet Parasitol. 2022;304:109696.","journal-title":"Vet Parasitol"},{"key":"7327_CR33","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1186\/s13071-020-04380-z","volume":"13","author":"B Alberigi","year":"2020","unstructured":"Alberigi B, Fernandes JI, Paiva JP, Mendes-de-Almeida F, Knackfuss F, Merlo A, et\u00a0al. Efficacy of semi-annual therapy of an extended-release injectable moxidectin suspension and oral doxycycline in Dirofilaria immitis naturally infected dogs. Parasit Vectors. 2020;13:503.","journal-title":"Parasit Vectors"},{"key":"7327_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2021.702018","volume":"8","author":"LS Jacobson","year":"2021","unstructured":"Jacobson LS, DiGangi BA. An accessible alternative to melarsomine: \u201cMoxi-Doxy\u201d for treatment of adult heartworm infection in dogs. Front Vet Sci. 2021;8:702018.","journal-title":"Front Vet Sci"},{"key":"7327_CR35","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1096\/fj.12-205096","volume":"26","author":"C Godel","year":"2012","unstructured":"Godel C, Kumar S, Koutsovoulos G, Ludin P, Nilsson D, Comandatore F, et\u00a0al. The genome of the heartworm, Dirofilaria immitis, reveals drug and vaccine targets. FASEB J. 2012;26:4650\u201361.","journal-title":"FASEB J"},{"key":"7327_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-017-2437-5","volume":"10","author":"C Bourguinat","year":"2017","unstructured":"Bourguinat C, Lefebvre F, Sandoval J, Bondesen B, Moreno Y, Prichard RK. Dirofilaria immitis JYD-34 isolate: whole genome analysis. Parasit Vectors. 2017;10:494.","journal-title":"Parasit Vectors"},{"key":"7327_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.crpvbd.2021.100007","volume":"1","author":"DC Lau","year":"2021","unstructured":"Lau DC, McLeod S, Collaery S, Peou S, Tran AT, Liang M, et\u00a0al. Whole-genome reference of Dirofilaria immitis from Australia to determine single nucleotide polymorphisms associated with macrocyclic lactone resistance in the USA. Curr Res Parasitol Vector Borne Dis. 2021;1:100007.","journal-title":"Curr Res Parasitol Vector Borne Dis"},{"key":"7327_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ani12111342","volume":"12","author":"S Gomes-de-S\u00e1","year":"2022","unstructured":"Gomes-de-S\u00e1 S, Barradas P, Queir\u00f3s-Reis L, Matas IM, Amorim I, Cardoso L, et\u00a0al. De novo assembly of the Dirofilaria immitis genome by long-read nanopore-based sequencing technology on an adult worm from a canine cardiopulmonary dirofilariosis case. Animals. 2022;12:1342.","journal-title":"Animals"},{"key":"7327_CR39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ijpara.2023.07.006","volume":"54","author":"J Gandasegui","year":"2024","unstructured":"Gandasegui J, Power RI, Curry E, Lau DC, O\u2019Neill CM, Wolstenholme A, et\u00a0al. Genome structure and population genomics of the canine heartworm Dirofilaria immitis. Int J Parasitol. 2024;54:89\u201398.","journal-title":"Int J Parasitol"},{"key":"7327_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-025-09250-x","volume":"9","author":"RI Power","year":"2026","unstructured":"Power RI, Abdullah S, Walden HS, Verocai GG, Sanders TL, Luksovsky JL, et\u00a0al. Population genomics reveals an ancient origin of heartworms in canids. Commun Biol. 2026;9:68.","journal-title":"Commun Biol"},{"key":"7327_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111522","volume":"41","author":"SR Doyle","year":"2022","unstructured":"Doyle SR, Laing R, Bartley D, Morrison A, Holroyd N, Maitland K, et\u00a0al. Genomic landscape of drug response reveals mediators of anthelmintic resistance. Cell Rep. 2022;41:111522.","journal-title":"Cell Rep"},{"key":"7327_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010545","volume":"18","author":"R Laing","year":"2022","unstructured":"Laing R, Doyle SR, McIntyre J, Maitland K, Morrison A, Bartley DJ, et\u00a0al. Transcriptomic analyses implicate neuronal plasticity and chloride homeostasis in ivermectin resistance and response to treatment in a parasitic nematode. PLoS Pathog. 2022;18:e1010545.","journal-title":"PLoS Pathog"},{"key":"7327_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetpar.2025.110536","volume":"338","author":"TG Geary","year":"2025","unstructured":"Geary TG, Drake J, Gilleard JS, Jesudoss Chelladurai JRJ, Jimenez Castro PP, Kaplan RM, et\u00a0al. Multiple anthelmintic drug resistance in the canine hookworm Ancylostoma caninum: AAVP position paper and research needs. Vet Parasitol. 2025;338:110536.","journal-title":"Vet Parasitol"},{"key":"7327_CR44","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.25.01.0027","volume":"86","author":"TA Quintana","year":"2025","unstructured":"Quintana TA, Karwath GN, Mayhue EJ, Jugan MC, Jesudoss Chelladurai JRJ, Martinez SE. Topical and oral emodepside formulations for last-line treatment of multianthelmintic drug-resistant hookworms when given orally to dogs are not bioequivalent. Am J Vet Res. 2025;86:ajvr.25.01.0027.","journal-title":"Am J Vet Res"},{"key":"7327_CR45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijpddr.2021.07.005","volume":"17","author":"MP H\u00fcbner","year":"2021","unstructured":"H\u00fcbner MP, Townson S, Gokool S, Tagboto S, Maclean MJ, Verocai GG, et\u00a0al. Evaluation of the in vitro susceptibility of various filarial nematodes to emodepside. Int J Parasitol Drugs Drug Resist. 2021;17:27\u201335.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"7327_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009682","volume":"17","author":"J Kr\u00fccken","year":"2021","unstructured":"Kr\u00fccken J, Holden-Dye L, Keiser J, Prichard RK, Townson S, Makepeace BL, et\u00a0al. Development of emodepside as a possible adulticidal treatment for human onchocerciasis\u2014The fruit of a successful industrial\u2013academic collaboration. PLoS Pathog. 2021;17:e1009682.","journal-title":"PLoS Pathog"},{"key":"7327_CR47","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1056\/NEJMoa2212825","volume":"388","author":"EC Mrimi","year":"2023","unstructured":"Mrimi EC, Welsche S, Ali SM, Hattendorf J, Keiser J. Emodepside for\u00a0Trichuris trichiura\u00a0and hookworm infection. N Engl J Med. 2023;388:1863\u201375.","journal-title":"N Engl J Med"},{"key":"7327_CR48","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/jvp.12149","volume":"38","author":"S Elmsh\u00e4user","year":"2015","unstructured":"Elmsh\u00e4user S, Straehle LC, Kranz J, Krebber R, Geyer J. Brain penetration of emodepside is increased in P-glycoprotein-deficient mice and leads to neurotoxicosis. J Vet Pharmacol Ther. 2015;38:74\u20139.","journal-title":"J Vet Pharmacol Ther"},{"key":"7327_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2019.00296","volume":"6","author":"D Gaens","year":"2019","unstructured":"Gaens D, Leith\u00e4user C, Hamann M, Geyer J. Adverse drug reactions after administration of emodepside\/praziquantel (Profender\u00ae) in an MDR1-mutant Australian Shepherd dog: case report. Front Vet Sci. 2019;6:296.","journal-title":"Front Vet Sci"},{"key":"7327_CR50","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ijpddr.2019.05.001","volume":"10","author":"JE Hodgkinson","year":"2019","unstructured":"Hodgkinson JE, Kaplan RM, Kenyon F, Morgan ER, Park AW, Paterson S, et\u00a0al. Refugia and anthelmintic resistance: concepts and challenges. Int J Parasitol Drugs Drug Resist. 2019;10:51\u20137.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"7327_CR51","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/bs.apar.2025.07.002","volume":"128","author":"F Kr\u00e4mer","year":"2025","unstructured":"Kr\u00e4mer F, Baneth G, Dantas-Torres F, Hamer S, Lappin MR, Otranto D, et\u00a0al. Resistance of companion animal parasites to antiparasitic drugs. Adv Parasitol. 2025;128:35\u2013157.","journal-title":"Adv Parasitol"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-026-07327-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-026-07327-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-026-07327-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:01:53Z","timestamp":1773871313000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13071-026-07327-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7327"],"URL":"https:\/\/doi.org\/10.1186\/s13071-026-07327-y","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"I am a consultant for several animal health companies, but none influenced the contents of this manuscript in any way.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}